For the first time, doctors used a gene-editing therapy tailored to a baby’s life-threatening, genetic disorder, a step toward more personalized care for rare disease patients:

When Meaghen stopped meeting developmental milestones, her mother Marissa began a search for answers. A genetic test helped reveal the true source of Meaghen’s condition and helped Marissa become a better advocate for her daughter. Read her story here:

Ten years after testing positive for a BRCA2 variant, cancer has touched Amanda’s family in more ways than one. She reflects on how preventive measures helped protect her health and why open communication with her kids is key. Read Amanda’s story:

Join us in celebrating Genetic Counselor Awareness Day! We honor the incredible contributions of genetic counselors and the invaluable role they play in healthcare. Let's show our appreciation for all that they do. #GeneticCounselorAwarenessDay Invitae is now part of Labcorp.

Want to learn about mainstreaming models for cancer risk assessment and genetic testing? Join us Saturday, Nov 16 at #CGAIGC2024 for our symposium from 12:30–1:30 pm. Click here to learn more: https://t.co/VYbfeMsFPJ Invitae is part of #Labcorp

Join us at booth #650 at ASHG to learn how we’re transforming variant classification with the power of machine learning to reclassify uncertain results. https://t.co/D5rNUSUNm8 #ASHG #VUSReclassification Invitae is now part of Labcorp.

Want to learn more about the evolution of our rigorous approach to variant classification? Join our scientific experts at #ASHG booth #650 to learn more about Invitae Generation™ and how we continue to update our innovative technologies.

Attending #CGAIGC24? Stop by booth #3 to learn how we can help inform #colorectalcancer #gicancer #polyposis care with our hereditary cancer #GeneticTesting.

Planning for #ASHG? Visit booth #650 to learn about the latest updates to Invitae Generation™ and our variant classification methods. Learn more: https://t.co/CaJoEgldGn

As far as Sarah knew, breast cancer didn’t run in her family. The results of one genetic test changed everything: Sarah discovered she was positive for BRCA1, which significantly increased her lifetime risk of developing breast and ovarian cancer.

Insights gained from genetic testing for hereditary cancer can impact medical recommendations. In fact, the American Society of Breast Surgeons (ASBrS) recommends genetic testing for all patients with breast cancer. Learn more: https://t.co/b1LP6hlY14 #BCAM

When Noah began having cardiac arrests at 18 months old, his doctors couldn’t figure out why. An exome sequencing test helped reveal the genetic source of his cardiac arrests and gave his parents more certainty about how to protect his health. Read more:

As we honor and support survivors and patients during Breast Cancer Awareness Month, take a moment to explore how #genetictesting can be a powerful tool for helping your patients take care of their health. Learn how we make testing easy: https://t.co/b1LP6hlY14 #BCAM

There is still time to register. Join us for this live webinar presented on October 10 at 12 pm ET/9 am PT and earn CEUs by attending. Register: https://t.co/sTCGBsJOLx #genetictesting #GCchat

Interested in exploring Sherloc? Join us for a live webinar presented on October 10 at 12 pm ET/9 am PT and earn CEUs by attending. Register now: https://t.co/sTCGBsJOLx #genetictesting #GCchat

Are you testing all of your ovarian cancer patients? Learn more about #genetictesting recommendations for your patient. https://t.co/uec4OKwd5k #OvarianCancerAwarenessMonth

The evolution of Sherloc: Insights into the innovative and scalable approaches impacting variant classification. Join us for this live webinar presented on October 10 at 12 pm ET/9 am PT and earn CEUs by attending. Register: https://t.co/sTCGBsJOLx #genetictesting #GCchat

Large genetic datasets can help researchers and biopharma teams develop much-needed treatments for rare diseases. Learn how our huge set of de-identified patient data helps support these efforts.

Attending #NSGC24? Join us and professional resume writer, Carey Hunter, MA, CPRW, at booth #527 for mini-workshops between sessions and personalized resume advice. Submit your resume in advance to guarantee a professional review https://t.co/JuZhQD3fPV

A new clinical utility study shows that genetic test results can affect treatment and follow-up recommendations for patients with prostate cancer. Read the study: